Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Kiadis Pharma
company
About
Kiadis Pharma is a biopharmaceutical company offering novel treatment options for terminally ill cancer patients.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €10M
- Industries
- Biopharma,Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 1997
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Kiadis Pharma is a biopharmaceutical company focused on complications and limitations of hematopoietic stem cell transplants in blood cancer patients. The company has three blood cancer products in clinical development that offer novel treatment options for terminally ill cancer patients addressing high-unmet medical needs. Kiadis Pharma is headquartered in Amsterdam, The Netherlands.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
€60M
Kiadis Pharma has raised a total of
€60M
in funding over 2 rounds. Their latest funding was raised on
Aug 1, 2018 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 1, 2018 | Post-IPO Debt | €20M | 1 |
Kreos Capital
|
— | Detail |
| Aug 17, 2017 | Post-IPO Debt | €15M | 1 |
Kreos Capital
|
— | Detail |
| Nov 20, 2012 | Series Unknown | €10M | 1 | — | — | Detail |
| Jun 26, 2007 | Series Unknown | €15M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
Kiadis Pharma is funded by 3 investors.
Kreos Capital
and Molten Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Kreos Capital
|
Yes | Post-IPO Debt |
Molten Ventures
|
— | Series Unknown |
MedSciences Capital
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
